The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Span-America Medical Systems Inc

Nasdaq: SPAN
Last

(U.S.) $17.10

Today's change-0.27 -1.55%
Updated December 26 3:59 PM -5GMT. Delayed by at least 15 minutes.
 

Span-America Medical Systems Inc

Nasdaq: SPAN
Last

(U.S.) $17.10

Today's change-0.27 -1.55%
Updated December 26 3:59 PM -5GMT. Delayed by at least 15 minutes.

Span-America Medical Systems Inc down (U.S.)$0.27

Span-America Medical Systems Inc closed sharply lower Friday, dropping (U.S.)$0.27 or 1.55% to (U.S.)$17.10. Over the last five days, shares have lost 3.01% and sit 3.20% above their 52-week low. This security has underperformed the S&P 500 by 27.29% during the last year.

Key company metrics

  • Open(U.S.) $17.60
  • Previous close(U.S.) $17.37
  • High(U.S.) $17.60
  • Low(U.S.) $17.00
  • Bid / Ask-- / --
  • YTD % change-17.95%
  • Volume4,011
  • Average volume (10-day)3,479
  • Average volume (1-month)4,113
  • Average volume (3-month)4,123
  • 52-week range(U.S.) $16.57 to (U.S.) $25.02
  • Beta0.33
  • Trailing P/E19.73×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield3.51%
  • Trailing EPS(U.S.) $0.87
Updated December 26 3:59 PM -5GMT. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014Dec 28, 201312/28/2013
Revenue13131515
Total other revenue--------
Total revenue13131515
Gross profit4455
Total cost of revenue99910
Total operating expense12131314
Selling / general / administrative3443
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income1111
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1111
Income after tax1011
Income tax, total0000
Net income1011
Total adjustments to net income--------
Net income before extra. items1011
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1011
Inc. avail. to common incl. extra. items1011
Diluted net income1011
Dilution adjustment0------
Diluted weighted average shares3333
Diluted EPS excluding extraordinary itemsvalue per share0.220.130.300.22
Dividends per sharevalue per share0.150.140.140.14
Diluted normalized EPSvalue per share0.220.130.300.22